AdvaMed Comments on EPA EtO Standards
AdvaMed submitted comments on the EPA’s proposed reconsideration of ethylene oxide (EtO) emissions standards for sterilization facilities, emphasizing the need for a balanced approach that safeguards both patient access to critical medtech. These comments highlight the importance of regulatory clarity, feasible compliance timelines, and continued collaboration with stakeholders to avoid disruptions in the availability of sterile medical products while advancing environmental protections.